PMC:7205724 / 748-976 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"56","span":{"begin":36,"end":44},"obj":"Species"},{"id":"57","span":{"begin":102,"end":111},"obj":"Species"},{"id":"58","span":{"begin":143,"end":151},"obj":"Species"},{"id":"67","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"68","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"69","span":{"begin":164,"end":172},"obj":"Disease"}],"attributes":[{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"Tax:9606"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"Tax:2697049"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:9606"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:C000657245"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:C000657245"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":24,"end":30},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"T9","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"T10","span":{"begin":102,"end":106},"obj":"Disease"},{"id":"T11","span":{"begin":164,"end":172},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":24,"end":30},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T4","span":{"begin":112,"end":115},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T9","span":{"begin":14,"end":22},"obj":"Species"},{"id":"T10","span":{"begin":60,"end":68},"obj":"Species"},{"id":"T11","span":{"begin":102,"end":111},"obj":"Species"},{"id":"T12","span":{"begin":164,"end":172},"obj":"Species"}],"attributes":[{"id":"A9","pred":"ncbi_taxonomy_id","subj":"T9","obj":"NCBItxid:2697049"},{"id":"A10","pred":"ncbi_taxonomy_id","subj":"T10","obj":"NCBItxid:2697049"},{"id":"A11","pred":"ncbi_taxonomy_id","subj":"T11","obj":"NCBItxid:2697049"},{"id":"A12","pred":"ncbi_taxonomy_id","subj":"T12","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T13","span":{"begin":24,"end":173},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"67","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"56","span":{"begin":36,"end":44},"obj":"Species"},{"id":"68","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"57","span":{"begin":102,"end":111},"obj":"Species"},{"id":"58","span":{"begin":143,"end":151},"obj":"Species"},{"id":"69","span":{"begin":164,"end":172},"obj":"Disease"}],"attributes":[{"id":"A67","pred":"pubann:denotes","subj":"67","obj":"MESH:C000657245"},{"id":"A56","pred":"pubann:denotes","subj":"56","obj":"Tax:9606"},{"id":"A68","pred":"pubann:denotes","subj":"68","obj":"MESH:C000657245"},{"id":"A57","pred":"pubann:denotes","subj":"57","obj":"Tax:2697049"},{"id":"A58","pred":"pubann:denotes","subj":"58","obj":"Tax:9606"},{"id":"A69","pred":"pubann:denotes","subj":"69","obj":"MESH:C000657245"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T118","span":{"begin":2,"end":9},"obj":"NNS"},{"id":"T119","span":{"begin":10,"end":13},"obj":"IN"},{"id":"T120","span":{"begin":14,"end":22},"obj":"NN"},{"id":"T121","span":{"begin":24,"end":30},"obj":"NN"},{"id":"T122","span":{"begin":31,"end":35},"obj":"IN"},{"id":"T123","span":{"begin":36,"end":44},"obj":"NNS"},{"id":"T124","span":{"begin":45,"end":54},"obj":"VBN"},{"id":"T125","span":{"begin":55,"end":59},"obj":"IN"},{"id":"T126","span":{"begin":60,"end":68},"obj":"NN"},{"id":"T127","span":{"begin":69,"end":73},"obj":"WDT"},{"id":"T128","span":{"begin":74,"end":82},"obj":"VBZ"},{"id":"T129","span":{"begin":83,"end":93},"obj":"NNS"},{"id":"T130","span":{"begin":94,"end":101},"obj":"IN"},{"id":"T131","span":{"begin":102,"end":111},"obj":"NN"},{"id":"T132","span":{"begin":112,"end":115},"obj":"VBZ"},{"id":"T133","span":{"begin":116,"end":121},"obj":"VBN"},{"id":"T134","span":{"begin":122,"end":131},"obj":"JJ"},{"id":"T135","span":{"begin":132,"end":139},"obj":"NNS"},{"id":"T136","span":{"begin":140,"end":142},"obj":"IN"},{"id":"T137","span":{"begin":143,"end":151},"obj":"NNS"},{"id":"T138","span":{"begin":152,"end":156},"obj":"IN"},{"id":"T139","span":{"begin":157,"end":163},"obj":"JJ"},{"id":"T140","span":{"begin":164,"end":172},"obj":"NN"},{"id":"T141","span":{"begin":174,"end":178},"obj":"RB"},{"id":"T142","span":{"begin":178,"end":179},"obj":"-COMMA-"},{"id":"T143","span":{"begin":180,"end":184},"obj":"NNP"},{"id":"T144","span":{"begin":184,"end":185},"obj":"-COMMA-"},{"id":"T145","span":{"begin":186,"end":194},"obj":"VBN"},{"id":"T146","span":{"begin":195,"end":199},"obj":"IN"},{"id":"T147","span":{"begin":200,"end":213},"obj":"NN"},{"id":"T148","span":{"begin":214,"end":216},"obj":"IN"}],"relations":[{"id":"R113","pred":"arg2Of","subj":"T120","obj":"T119"},{"id":"R114","pred":"arg1Of","subj":"T121","obj":"T122"},{"id":"R115","pred":"arg2Of","subj":"T123","obj":"T122"},{"id":"R116","pred":"arg2Of","subj":"T123","obj":"T124"},{"id":"R117","pred":"arg1Of","subj":"T124","obj":"T125"},{"id":"R118","pred":"arg2Of","subj":"T126","obj":"T125"},{"id":"R119","pred":"arg1Of","subj":"T126","obj":"T127"},{"id":"R120","pred":"arg1Of","subj":"T126","obj":"T128"},{"id":"R121","pred":"arg2Of","subj":"T129","obj":"T128"},{"id":"R122","pred":"arg1Of","subj":"T129","obj":"T130"},{"id":"R123","pred":"arg2Of","subj":"T131","obj":"T130"},{"id":"R124","pred":"arg1Of","subj":"T121","obj":"T132"},{"id":"R125","pred":"arg2Of","subj":"T133","obj":"T132"},{"id":"R126","pred":"arg1Of","subj":"T121","obj":"T133"},{"id":"R127","pred":"arg2Of","subj":"T135","obj":"T133"},{"id":"R128","pred":"arg1Of","subj":"T135","obj":"T134"},{"id":"R129","pred":"arg1Of","subj":"T133","obj":"T136"},{"id":"R130","pred":"arg2Of","subj":"T137","obj":"T136"},{"id":"R131","pred":"arg1Of","subj":"T137","obj":"T138"},{"id":"R132","pred":"arg2Of","subj":"T140","obj":"T138"},{"id":"R133","pred":"arg1Of","subj":"T140","obj":"T139"},{"id":"R136","pred":"arg1Of","subj":"T143","obj":"T144"},{"id":"R137","pred":"arg2Of","subj":"T143","obj":"T145"},{"id":"R138","pred":"arg1Of","subj":"T145","obj":"T146"},{"id":"R139","pred":"arg2Of","subj":"T147","obj":"T146"},{"id":"R140","pred":"arg1Of","subj":"T147","obj":"T148"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T2","span":{"begin":24,"end":30},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T8","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"T9","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"T10","span":{"begin":102,"end":111},"obj":"Disease"},{"id":"T11","span":{"begin":164,"end":172},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}

{"project":"LitCovid-sentences","denotations":[{"id":"T13","span":{"begin":24,"end":173},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"c options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticoster"}